Prolonged suppression of experimental allergic encephalomyelitis in the Lewis rats: the effect of lipopolysaccharides
Raziuddin, S.; Morrison, D.C.
Journal of Immunology 128(3): 1486-1489
1982
ISSN/ISBN: 0022-1767 PMID: 6173441 Document Number: 196410
The current investigations have revealed that Lewis rats preimmunized with BP in CFA, and after recovery from the first episode of EAE, developed a second mild attack of EAE after challenge with BP/CFA at specified times. However, preimmunization of Lewis rats with BP complexed to LPS in CFA protects animals for a longer time from a second attack induced by BP/CFA challenge.
Document emailed within 1 workday
Related Documents
Paterson, P.Y.; Harvey, J.M.; Webster, L.T. 1977: Niridazole suppression of experimental allergic encephalomyelitis in Lewis rats Journal of Immunology 118(6): 2151-2154Zaprianova, E.; Deleva, D.; Bakalska, M.; Filchev, N. 1997: Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis Morfologiia 112(6): 25-28
Dal Canto, M.C.; Fujinami, R.S.; Paterson, P.Y. 1977: Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals Laboratory Investigation; a Journal of Technical Methods and Pathology 37(4): 395-405
Kasckow, J.W.; Tabira, T.; Itoyama, Y.; Kuroiwa, Y.; Takenaka, A.; Nagai, Y. 1981: Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug Japanese Journal of Experimental Medicine 51(5): 293-298
Tateyama, M. 1988: Mechanism of suppression of colchicine in experimental allergic encephalomyelitis Hokkaido Journal of Medical Science 63(1): 72-79
Levine, S.; Sowinski, R. 1977: Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs Archives Internationales de Pharmacodynamie et de Therapie 230(2): 309-318
Wojcik, W.J.; Swoveland, P.; Zhang, X.; Vanguri, P. 1996: Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat Journal of Pharmacology and Experimental Therapeutics 278(1): 404-410
Hughes, D.; Keith, A.B.; Mertin, J.; Caspary, E.A. 1980: Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment Clinical and Experimental Immunology 40(3): 523-531
Happ, M.P.; Wettstein, P.; Dietzschold, B.; Heber-Katz, E. 1988: Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects Journal of Immunology 141(5): 1489-1494
Zhitnukhin, I.L.; Litvinenko, I.V.; Ogurtsov, R.P. 1998: Effect of nicotinamide on development of experimental allergic encephalomyelitis Biulleten' Eksperimental'noi Biologii i Meditsiny 125(2): 180-182
Elliott, G.A.; Gibbons, A.J.; Greig, M.E. 1973: Therapeutic effects of melengestrol acetate, cyclophosphamide and palmitoyl cytarabine in established experimental allergic encephalomyelitis of rats Archives Internationales de Pharmacodynamie et de Therapie 204(1): 62-76
Matsushima, S.; Yoshitoshi, T.; Mahalak, S.M.; Shichi, H. 1990: Immunosuppressive effect of gramicidin S on experimental ocular neuritis and allergic encephalomyelitis Japanese Journal of Ophthalmology 34(3): 306-313
Abdarasulova, I.N.; Serdiuk, S.E.; Gmiro, V.E. 2007: Combined blockade of GluR1 AMPA and NMDA receptors effectively eliminates neurological disorders in rats with experimental allergic encephalomyelitis Eksperimental'naia i Klinicheskaia Farmakologiia 70(4): 15-19
Kraft, G.H.; Slimp, J.C. 1984: Electrophysiological monitoring of experimental allergic neuritis and experimental allergic encephalomyelitis Progress in Clinical and Biological Research 146: 449-453
Sriram, S.; Carroll, L.; Fortin, S.; Cooper, S.; Ranges, G. 1988: In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis Journal of Immunology 141(2): 464-468
Watanabe, R.; Wege, H.; ter Meulen, V. 1987: Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats Laboratory Investigation; a Journal of Technical Methods and Pathology 57(4): 375-384
Willenborg, D.O.; Danta, G. 1985: Experimental allergic encephalomyelitis: effect of neonatal exposure to neuroantigen or neuroantigen immune cells on subsequent reactivity as adults Clinical and Experimental Neurology 21: 226-231
Raine, C.S.; Wisniewski, H.; Dowling, P.C.; Cook, S.D. 1971: An ultrastructural study of experimental demyelination and remyelination. IV. Recurrent episodes and peripheral nervous system plaque formation in experimental allergic encephalomyelitis Laboratory Investigation; a Journal of Technical Methods and Pathology 25(1): 28-34
Kawai, K.; Kobayashi, Y.; Miyasaka, M.; Yoshikai, Y.; Sobue, G. 1995: Suppression of experimental autoimmune encephalomyelitis with antibodies against adhesion molecules Rinsho Shinkeigaku 35(12): 1504
Khizhniak, M.G.; Zhitnukhin, I.L.; Konovalov, G.V. 1987: Dynamics of pathomorphologic changes in experimental allergic encephalomyelitis Arkhiv Patologii 49(3): 54-60